Home / Expert Answers / Nursing / a-randomized-double-blinded-placebo-controlled-trial-in-692-subjects-with-mild-moderate-alzheimer-pa648

(Solved): A randomized, double-blinded, placebo-controlled trial in 692 subjects with mild-moderate Alzheimer ...



A randomized, double-blinded, placebo-controlled trial in 692 subjects with mild-moderate Alzheimer’s disease to evaluate the efficacy and safety of NO-AD, a tree-derived carbohydrate that targets beta-amyloid, neuroinflammation, and other manifestations of the disease. Subjects received either 250 mg of the study drug or a placebo twice per day. The primary outcome measure was improvement on the ADAS-cog after 36 weeks.: To which of the clinical stages the above description belong?: 1. Pre-clinical research 2. Phase 1 clinical trial 3. Phase 2 clinical trial 4. Phase 3 clinical trial



We have an Answer from Expert

View Expert Answer

Expert Answer


We have an Answer from Expert

Buy This Answer $5

Place Order

We Provide Services Across The Globe